Piper Jaffray Warns on Recent Contract Action for MedAssets (MDAS); Shares Moving Lower
Tweet
Share
E-mailGet Alerts MDAS Hot Sheet
Price: $31.35 --0%
Rating Summary:
3 Buy, 20 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
3 Buy, 20 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Shares of MedAssets (Nasdaq: MDAS) might be trading lower on the heels of a concerning research note from Piper Jaffray's Sean Wieland Monday morning. The stock last traded at $11.71, down about 1.8 percent from Friday's close.
Wieland warned recent failures to win three high-profile contracts may end up putting pressure on sales within its GPO segment.
The firm maintains an Underweight rating and $10 price target on shares of MedAssets.
Wieland warned recent failures to win three high-profile contracts may end up putting pressure on sales within its GPO segment.
The firm maintains an Underweight rating and $10 price target on shares of MedAssets.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
- Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'
- Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
